169044-98-8 Usage
Uses
Used in Pharmaceutical Industry:
1H-Isoindol-1-one,7-amino-2,3-dihydro-(9CI) is used as a building block for the synthesis of pharmaceuticals due to its versatile chemical structure and potential biological activity. It can be incorporated into the development of new drugs and therapeutic agents, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
1H-Isoindol-1-one,7-amino-2,3-dihydro-(9CI) is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows for the formation of diverse chemical entities, making it a valuable component in organic chemistry.
Used in Dye and Pigment Production:
1H-Isoindol-1-one,7-amino-2,3-dihydro-(9CI) is used as a precursor in the production of dyes and pigments. Its chemical properties enable the creation of a wide range of colorants for various applications, including textiles, plastics, and printing inks.
Used in Drug Discovery:
1H-Isoindol-1-one,7-amino-2,3-dihydro-(9CI) has potential applications in drug discovery due to its biological activity. It can be further researched and developed to identify its therapeutic potential and contribute to the discovery of new drugs and treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 169044-98-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,0,4 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 169044-98:
(8*1)+(7*6)+(6*9)+(5*0)+(4*4)+(3*4)+(2*9)+(1*8)=158
158 % 10 = 8
So 169044-98-8 is a valid CAS Registry Number.
169044-98-8Relevant articles and documents
2,4-DI(AMINOPHENYL) PYRIMIDINES AS PLK INHIBITORS
-
Page/Page column 26, (2008/06/13)
The invention relates to compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1, and R3 are defined as indicated in claim 1. Said compounds are used for the treatment of diseases characterized by excessive or anomalous cell proliferation. Also disclosed is the use of the inventive compounds for producing a medicament having said properties.